As OpenAI files for IPO, Sam Altman’s eye-scanning company is doing layoffs, report says

2026-06-08 · Source: TechCrunch · Field: Technology & Digital — Artificial Intelligence & Machine Learning, Blockchain & Distributed Ledger Technology, FinTech & Digital Financial Services · Depth: Fundamental Awareness, quick

Summary

OpenAI confidentially filed for an IPO on Monday, positioning itself for a potentially defining public offering of the decade. Concurrently, Sam Altman's other venture, Tools for Humanity, is reportedly undergoing layoffs. This company, known for its World project, utilizes iris scans via a "creepy silver orb" to verify human identities against bots and validate trades of its Worldcoin cryptocurrency. Despite raising funds at a \$2.5 billion valuation from investors including Andreessen Horowitz and Bain Capital, Tools for Humanity is downsizing due to revenue generation challenges. The company has also encountered significant regulatory and ethical scrutiny, with Kenya banning its operations over privacy and financial concerns, and South Korea imposing an \$830,000 fine for alleged privacy law violations, particularly concerning the offer of \$50 in Worldcoin for biometric data.

Key takeaway

For investors evaluating high-profile tech ventures, Sam Altman's dual narrative underscores significant risk factors. While OpenAI's IPO signals growth, your due diligence must extend to the ethical and regulatory challenges faced by related projects like Tools for Humanity. Its struggles with revenue and international bans over biometric data collection highlight that even well-funded, ambitious projects can falter under public and governmental scrutiny. Consider the broader ecosystem and potential liabilities associated with controversial data practices.

Key insights

Sam Altman's ventures present a dichotomy: OpenAI's IPO ambition contrasts with Tools for Humanity's struggles with biometric data ethics and regulation.

Principles

• Biometric data collection for financial incentives faces intense regulatory scrutiny.
• High valuations do not guarantee revenue generation or ethical compliance.

In practice

• Thoroughly vet biometric data collection strategies against global privacy laws.
• Anticipate public and regulatory skepticism when linking biometrics to cryptocurrency.

Topics

• OpenAI IPO
• Tools for Humanity
• Worldcoin
• Biometric Data
• Regulatory Compliance
• Data Privacy

Best for: CTO, VP of Engineering/Data, Director of AI/ML, Tech Journalist, Investor, General Interest

Related on AIssential

• Week one of the Musk v. Altman trial: What it was like in the room — The Musk v. Altman trial exposes the complex legal and ethical challenges in AI's commercialization.
• AI Impact Summit 2026: OpenAI chief Sam Altman calls for ‘urgent’ global AI regulation - Mint — Urgent international AI regulation, potentially via an IAEA-like body, is needed to manage risks while ensuring broad access.
• The most profound and least understood risk facing AI developers is endogenous: the very technology they are building is rapidly acquiring the computational and analytical capability... — AI's inherent analytical power is exposing its creators' unsustainable financial, legal, and technical vulnerabilities.
• 😼 Sam Altman's principles arrived one day too late — OpenAI's stated principles face scrutiny when measured against internal practices and real-world accountability challenges.
• The $3 Trillion Heist: Why Sam Altman and Elon Musk Are Rushing to Go Public Before It’s Too Late — A coordinated $3 trillion IPO wave from OpenAI, Anthropic, and SpaceX is anticipated by 2026.
• Sam Altman Wants the Government to Own a Piece of OpenAI — Government equity in AI firms is proposed to align public interest with AI growth and mitigate distrust.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by TechCrunch.